Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Barry Mandell (NPI 1972587491)

Field	Value
Entity Type	Individual
Organization	Barry Mandell
Address	397 Little Neck Rd
City	Virginia Beach
State	VA
ZIP	23452
Taxonomy	Ophthalmology Physician
NPI Enumerated	November 30, 2005

Payer Source	Total Paid
Medicare	$3.3M
Medicaid	$0

Key Findings

This provider bills almost exclusively to Medicare with Total Medicare revenue of $3.3M and no Medicaid billing on file, making their effective payer mix single-payer in scope; analyses of Medicaid activity are not possible because there is none below. The absence of Medicaid billing suggests the practice’s Medicare footprint drives its entire observed revenue and any payer-strategy assessment should start from that concentration.

Revenue is highly concentrated in a very small set of codes: the precomputed top-3 Medicare codes account for 88.7% of this provider's total Medicare revenue. Those top three are J0178 ($1.4M revenue, 44.1% of this provider's total Medicare revenue), J2777 ($1.3M revenue, 39.3% of this provider's total Medicare revenue), and 67028 ($175.9K revenue, 5.4% of this provider's total Medicare revenue), indicating most billing dollars are tied to a narrow set of injectable therapies and the injection procedure. This concentration makes the provider’s topline sensitive to utilization or reimbursement shifts for these specific drugs and the associated injection procedure.

The code mix is consistent with a retina-focused ophthalmology practice that predominantly delivers intravitreal biologic therapy: J0178 (aflibercept) and J2777 (faricimab) together drive the bulk of revenue and 67028 documents the intravitreal injection procedure itself. Supporting services—high volumes of 92012 (intermediate established eye exams) and 92134 (retinal imaging)—fit a workflow of repeat therapeutic injections with ongoing monitoring and follow-up visits. This pattern aligns clinical operations around regular in-office injections, follow-up E/Ms, and retina imaging rather than surgical retina or broad ophthalmic subspecialty services.

Competitive standing on the injectable agents is above typical national activity but not extreme: J0178 ranks #492 of 3204 providers nationally (85th percentile; typical, unremarkable volume for this code) and J2777 ranks #137 of 2039 providers nationally (93th percentile; typical, unremarkable volume for this code), while the injection procedure 67028 ranks #443 of 4255 providers nationally (90th percentile; typical, unremarkable volume for this code). These rank/percentile positions indicate the provider treats more patients with these agents than most peers but is not a national outlier or dominant provider for these services.

There are notable statistical outliers among non-top-3 services that illuminate practice patterns: 92012 is an extreme outlier (rank #84 of 17177 providers nationally, 100th percentile; extreme outlier, far above typical national volume for this code), and 92134 is notably above typical national volume (rank #1045 of 26868 providers nationally, 96th percentile; notably above typical national volume for this code). High relative volumes for intermediate established exams and retinal imaging emphasize heavy ongoing monitoring and management of retinal disease in this practice.

Although not a top revenue driver, J3490 (Unclassified drugs) shows a high average paid/claim ($1967 avg paid/claim) with $45.2K revenue but a low national standing (rank #2509 of 2838 providers nationally, 10th percentile; typical, unremarkable volume for this code), suggesting occasional high-cost miscellaneous drug billing that is uncommon among peers. This pattern could reflect sporadic use of nonstandard or compounded medications billed under an unclassified code rather than a core, repeatable revenue stream.

The provider has an established tenure with NPI enumerated 2005-11-30 (~21 years ago), indicating a long-standing presence in the market that could support a stable referral base and consistent patient panel for recurrent intravitreal therapy workflows. That longevity, combined with the concentration in intravitreal therapies, suggests operational specialization rather than a broad general ophthalmology practice.

From an operational and risk perspective, the practice’s heavy reliance on two high-revenue biologic codes (J0178 and J2777 together representing 83.4% of total Medicare revenue when using the provided code shares of 44.1% and 39.3%) and the supporting injection procedure 67028 means reimbursement policy changes, shifts in drug mix, or formulary decisions affecting these agents could materially affect revenue. Payors evaluating network value should weigh the provider’s above-typical injection and monitoring volumes against the lack of Medicaid activity and concentrated revenue exposure when considering contracting or utilization management strategies.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,110	$690	$1.4M
J2777	Injection, faricimab‑svoa, 0.1 mg	44,460	$30	$1.3M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,930	$90	$175.9K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	1,940	$60	$124.2K
J2778	Injection, ranibizumab, 0.1 mg	330	$180	$59K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,990	$30	$57.6K
J3490	Unclassified drugs	20	$1,970	$45.2K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	300	$120	$36K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	130	$120	$15.6K
J9035	Injection, bevacizumab, 10 mg	260	$60	$14.5K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Barry Mandell — 1 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	27	80	1,400	$690	$1.1M
J2777	5	60	13,200	$30	$517.1K
J2778	32	40	560	$180	$171.5K
67028	21	90	1,000	$90	$107.1K
J2781	14	20	560	$120	$86.6K
92014	821	870	170	$80	$32.8K
J3490	91	110	60	$280	$20.5K
J9035	21	60	170	$50	$19.9K
92012	3	430	80	$60	$11.9K
92134	42	680	70	$30	$9.7K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Barry Mandell, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Adam Lipman	VA	Ophthalmology Physician	$3.7M	$0
Joaquin Tosi	VA	Retina Specialist (Ophthalmology) Physician	$105K	$22.4K

Nearby Providers

Other providers in the same ZIP code as Barry Mandell, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Support Services Of Virginia, Inc.	VA	Developmentally Disabled Services Day Training Agency	$0	$76.1M
Crescent Counseling & Casework Services Inc.	VA	Community/Behavioral Health Agency	$0	$25.3M
Hope Care & Love Home Healthcare Services LLC	VA	Home Health Agency	$0	$19M
Rehabilitation Associates Inc	VA	Pediatric Physical Therapist	$0	$18.2M
Family First Home Healthcare ,LLC	VA	Home Health Agency	$0	$17.4M
Seven Summits Family Services, LLC	VA	Community/Behavioral Health Agency	$0	$9.9M
Circle Of Life, LLC	VA	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$9.3M
Right Path Treatment Center LLC	VA	Addiction Medicine (Internal Medicine) Physician	$0	$9M
Reign Integrated Services	VA	Behavior Analyst	$0	$8.3M
C & R Divine Hands Of Care	VA	Home Health Agency	$0	$8.1M

Barry Mandell — Billing Profile & Reimbursement Data

Sign up for Barry Mandell — Billing Profile & Reimbursement Data policy alerts

Barry Mandell — Billing Profile & Reimbursement Data

Sign up for Barry Mandell — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References